Kubota Pharmaceutical Holdings Co., Ltd.

$65 JPY

-$3 (-4.41%)

Volume: 5.33M
Average Volume: 3.15M
Market Capitalization: $4.15B
P/E Ratio: -7.14
Dividend Yield: 0.00%
Price Target

Year High: $350.00
Year Low: $41.00
Day High: —
Day Low: —
Payout Ratio: $0.00
Current Ratio: $9.87

Industry, Sector & symbol

Stock Exchange	JPX
CEO	Ryo Kubota
Industry	Biotechnology
Sector	Healthcare
Current Symbol	4596.T
CUSIP	None
CIK	None
Web	https://www.kubotaholdings.co.jp
Phone	81 3 6550 8928
Currency	JPY
Employees	8
Country	JP

Liquidity

Debt-to-Equity Ratio	0.01
Payout Ratio	0.00
Current Ratio	9.87
Quick Ratio	9.84
Cash Ratio	9.52

Sales & Book Value

Annual Sales	$21.34M
Price / Sales	220.88
Cash Flow	-5.13
Price / Cash Flow	-6.67
Price / Book	4.70

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecast Upside/Downside	%
Consensus Rating	Sell
Rating Score(0-5)	2
Research Coverage	0 Analysts

Profitability

EPS (Most Recent Fiscal Year)	-$10.59
Trailing P/E Ratio	-7.14
PEG Ratio	-0.07
P/E Growth	-0.07
Net Income	-$676.25M
Net Margin	-3885.24%
Pretax Margin	-3885.24%
Return on Equity	-46.27%
Return on Assets	-39.15%

Financials Score

AltmanZ Score	-5.32
Piotroski Score	1.00
Working Capital	1.67B
Total Assets	1.86B
Ebit	-944.4M
Market Cap	4.66B
Total Liabilities	188.49M

Poll Results

About Kubota Pharmaceutical Holdings Co., Ltd. (JPX:4596.T) Stock

Kubota Pharmaceutical Holdings Co., Ltd., an international entity established in Tokyo, Japan, in 2002, focuses on the creation and advancement of a diverse range of pharmaceutical treatments and medical devices. A primary asset in their development pipeline is emixustat hydrochloride, a drug currently undergoing Phase III clinical trials for Stargardt disease and Phase II trials for proliferative diabetic retinopathy. Beyond its pharmaceutical endeavors, the company is also innovating in medical technology, specifically with a patient-centric ophthalmology suite designed for remote retinal monitoring. This advanced suite features both miniature, home-use optical coherence tomography (OCT) devices and high-resolution OCT technology adapted from NASA. Furthermore, Kubota Pharmaceutical Hold ... ings is developing a wearable device aimed at controlling myopia.

Frequently Asked Questions

What is the current Kubota Pharmaceutical Holdings Co., Ltd. (4596.T) stock price?: Kubota Pharmaceutical Holdings Co., Ltd.(JPX:4596.T) stock price is $65 in the last trading session. During the trading session, 4596.T stock reached the peak price of $350 while $41 was the lowest point it dropped to. The percentage change in 4596.T stock occurred in the recent session was --4.41% while the dollar amount for the price change in 4596.T stock was -$3.
4596.T's industry and sector of operation?: The JPX listed 4596.T is part of Biotechnology industry that operates in the broader Healthcare sector.
Who are the executives of 4596.T?: Kazutoshi Watanabe | Chief Financial Officer
Tomomi Sukagawa | Director of Investor Relations & Communication
Ryo Kubota | Founder, Chairman, Chief Executive Officer & President
|
|
How many employees does 4596.T have?: Number of 4596.T employees currently stands at 8. 4596.T operates from 3-7-1 Kasumigaseki, Tokyo, None None, JP.

Link for 4596.T official website?: Official Website of 4596.T is: https://www.kubotaholdings.co.jp
How do I contact 4596.T?: 4596.T could be contacted at phone #81 3 6550 8928 and can also be accessed through its website. 4596.T operates from 3-7-1 Kasumigaseki, Tokyo, None None, JP.
How many shares of 4596.T are traded daily?: The average number of 4596.T shares traded daily for last 3 months was 3.15M.
What is the market cap of 4596.T currently?: The market value of 4596.T currently stands at $4.15B with its latest stock price at $65